Latest News and Press Releases

BOTHELL, WA--(Marketwire - Nov 29, 2012) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that it has entered into a...

BOTHELL, WA--(Marketwire - Oct 11, 2012) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading RNAi-based drug discovery and development company, today reported financial results for the fiscal year...

BOTHELL, WA--(Marketwire - Aug 22, 2012) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company, today provided an update on its operations....

BOTHELL, WA--(Marketwire - Aug 3, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, announced today that it has entered into a...

BOTHELL, WA--(Marketwire - Jun 1, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that it does not currently have...

CINCINNATI, OH and HANNOVER, GERMANY and BOTHELL, WA--(Marketwire - May 21, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, and...

BOTHELL, WA--(Marketwire - May 10, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the U.S. Patent and...

BOTHELL, WA--(Marketwire - May 8, 2012) - Marina Biotech, Inc. (OTCQX: MRNA) announced today that it has entered into an exclusive licensing agreement with Monsanto Company for Marina Biotech's...

BOTHELL, WA--(Marketwire - Apr 19, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that it has regained intellectual...

BOTHELL, WA--(Marketwire - Apr 3, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced the completion of dosing for Cohort...